Robert C. Malenka serves as Executive at MapLight Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Robert C. Malenka has executed 4 insider transactions totaling $126.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 3, 2026 involved selling 1 shares valued at $18.
Robert C. Malenka currently holds 358,233 shares of MapLight Therapeutics, Inc. (MPLT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert C. Malenka has been a net seller of MPLT stock. They have purchased $0 and sold $126.9K worth of shares.
Robert C. Malenka's most recent insider trade was on Feb 3, 2026, when they sold 1 shares at $18.00 per share.
Get notified when new Form 4 filings are submitted
| $18.02 |
| Discretionary |
| Oct 28, 2025 | MPLT | $0 | Conversion | 3,895 | $N/A | Discretionary |
| Oct 27, 2025 | MPLT | $0 | Award | 34,390 | $N/A | Discretionary |